Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Topolsky

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Bone Marrow Transplantation|March 1, 1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantationP Crilley, D Topolsky, M J Styler, et al.
Bone Marrow Transplantation|February 1, 1991
Autologous bone marrow transplantation for advanced stage mycosis fungoidesR D Bigler, P Crilley, B Micaily, et al.
American Journal of Clinical Oncology|June 1, 1990
An unusual extramedullary relapse of acute nonlymphocytic leukemia after allogeneic bone marrow transplantationB P Kelch, S I Bulova, P Crilley, et al.
American Journal of Clinical Oncology|March 10, 2001
Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?R A Ener, S B Meglathery, B Cuhaci, et al.
Seminars in Oncology|August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Autologous stem cell transplantation for acute myeloid leukemia in first remissionC A Linker, C A Ries, L E Damon, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bone Marrow Transplantation|March 1, 1995
Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantationP Crilley, D Topolsky, M J Styler, et al.
Bone Marrow Transplantation|February 1, 1991
Autologous bone marrow transplantation for advanced stage mycosis fungoidesR D Bigler, P Crilley, B Micaily, et al.
American Journal of Clinical Oncology|June 1, 1990
An unusual extramedullary relapse of acute nonlymphocytic leukemia after allogeneic bone marrow transplantationB P Kelch, S I Bulova, P Crilley, et al.
American Journal of Clinical Oncology|March 10, 2001
Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?R A Ener, S B Meglathery, B Cuhaci, et al.
Seminars in Oncology|August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignanciesP Crilley, H Lazarus, D Topolsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphomaH M Lazarus, P Crilley, N Ciobanu, et al.
Bone Marrow Transplantation|July 1, 1996
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysisM J Styler, P Crilley, J Biggs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Autologous stem cell transplantation for acute myeloid leukemia in first remissionC A Linker, C A Ries, L E Damon, et al.
Pageof 2